Unspecified ocular prostaglandin analogue
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Unspecified ocular prostaglandin analogue, covering 2011-10-31 to 2011-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues [Phase 4]